Pathway-Based Methods for Analyzing Microarray Data

Analysis of Microarray Data: A Network-Based Approach

Volumn , Issue , 2008, Pages 355-384

  Pang, Herbert ^a   Kim, Inyoung ^b   Zhao, Hongyu ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Analysis; Biological pathways; DNA microarrays; Gene expression data; Machine learning methods; Markov chain Monte Carlo; Pathway based methods; Random forests; Real data analysis

Indexed keywords

EID: 77954819195     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527622818.ch13     Document Type: Chapter

References (54)

1. Pang, H., Lin, A., Holford, M., Enerson, B., Lu, B., Lawton, M., Floyd, E. and Zhao, H. (2006) Pathway analysis using random forests classification and regression. Bioinformatics (Oxford, England), 22, 2028-2036.
2. Kim, I., Pang, H. and Zhao, H. (2007) Bayesian semiparametric approach for gene pathway analysis. Technical Report.
3. Harris, M. and Gene Ontology Consortium (2004) The Gene Ontology (GO) database and informatics resource. Nucleic Acids Research, 32, D258-D261.
4. Mootha, V., Lindgren, C., Eriksson, K., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carsson, E., Ridderstrale, M., Laurila, E., Houstis, N., Daly, M., Patterson, P., Mesirov, J., Golub, T., Tamayo, P., Spiegelman, B., Lander, E., Hirschhorn, J., Altshuler, D. and Groop, L. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature Genetics, 34 (3), 267-273.
5. Subramanian, A., Tamayoa, P., Mootha, V., Mukherjee, S., Ebert, B., Gillette, M., Paulovich, A., Pomeroy, S., Golub, T., Lander, E. and Mesurov, J. (2005) Gene set enrichment analysis: a knowledgebased approach for interpreting genomewide expression profiles. Proceedings of the National Academy of Sciences of the United States of America, 102 (43), 15545-15550.
6. Efron, B. and Tibshirani, R. (2006) Testing the significance of sets of genes. Technical Report.
7. Newton, M., Quintana, F., den Boon, A., Sengupta, S. and Ahlquist, P. (2007) Random-set methods identify distinct aspects of the enrichment signal in geneset analysis. Annals of Applied Statistics, 1, 85-106.
8. Goeman, J., van de Geer, S., de Kort, F. and van Houwelingen, H. (2004) A global test for groups of genes: testing association with a clinical outcome. Bioinformatics (Oxford England), 20 (1), 93-99.
9. Mansmann, U. and Meister, R. (2005) Testing differential gene expression in functional groups. Goeman's global test versus an ANCOVA approach. Methods of Information in Medicine, 44 (3), 449-453.
10. Breiman, L. (2003) Manual on Setting Up, Using, and Understanding Random Forests, V4.0http://oz.berkeley.edu/users/breiman/Using_random_ forests_V4.0.pdf.
11. Svetnik, V., Liaw, A., Tong, C., Culberson, J., Sheridan, R. and Feuston, B. (2003) Random forest: a classification and regression tool for compound classification and QSAR modeling. Journal of Chemical Information and Computer Sciences, 43 (6), 1947-1958.
12. Wu, B., Abbott, T., Fishman, D., McMurray, W., Mor, G., Stone, K., Ward, D., Williams, K. and Zhao, H. (2003) Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data. Bioinformatics (Oxford England), 19 (13), 1636-1643.
13. Qi, Y., Bar-Joseph, Z. and Klein-Seetharaman, J. (2006) Evaluation of different biological data and computational classification methods for use in protein interaction prediction. Proteins, 63 (3), 490-500.
14. Breiman, L. (2001) Random forests. Machine Learning, 45, 5-32.
15. Farmer, P., Bonnefoi, H., Becette, V., Tubiana-Hulin, M., Fumoleau, P., Larsimont, D., Macgrogan, G., Bergh, J., Cameron, D., Goldstein, D., Duss, S., Nicoulaz, A., Brisken, C., Fiche, M., Delorenzi, M. and Iggo, R. (2005) Identification of molecular apocrine breast tumours by microarray analysis. Oncogene, 24 (29), 4660-4671.
16. Enerson, B., Lin, A., Lu, B., Zhao, H., Lawton, M. and Floyd, E. (2006) Acute drug-induced vascular injury in beagle dogs: pathology and correlating genomic expression. Toxicologic Pathology, 34 (1), 27-32.
17. Appella, E. and Anderson, C. (2001) Posttranslational modifications and activation of p53 by genotoxic stresses. European Journal of Biochemistry, 268 (10), 2764-2772.
18. Iida, T., Mine, S., Fujimoto, H., Suzuki, K., Minami, Y. and Tanaka, Y. (2002) HIF-1-induced apoptosis of endothelial cells. Genes to Cells, 7, 143-149.
19. Desai, A., Miller, M., Huang, X. and Warren, J. (2003) Nitric oxide modulates MCP-1 expression in endothelial cells: implications for the pathogenesis of pulmonary granulomatous vasculitis. Inflammation, 27 (4), 213-223.
20. Charo, I. and Taubman, M. (2004) Chemokines in the pathogenesis of vascular disease. Circulation Research, 95, 858.
21. Panzer, U., Steinmetz, O., Reinking, R., Meyer, T., Fehr, S., Schneider, A., Zahner, G., Wolf, G., Helmchen, U., Schaerli, P., Stahl, R. and Thaiss, F. (2006) Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury. Journal of the American Society of Nephrology, 17, 454-464.
22. Rothenbacher, D., Muller-Scholze, S., Herder, C., Koenig, W. and Kolb, H. (2005) Differential expression of chemokines risk of stable coronary heart disease, and correlation with established cardiovascular risk markers. Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 26-194.
23. Zhao, Y., Qin, S., Atangan, L., Molina, Y., Okawa, Y., Arpawong, H., Ghosn, C., Xiao, J., Vuligonda, V., Brown, G. and Chandraratna, R. (2004) Casein kinase 1alpha interacts with retinoid X receptor and interferes with agonist-induced apoptosis. Journal of Biochemistry, 279 (29), 30844-30849.
24. Bolick, D., Srinivasan, S., Whetzel, A., Fuller, L. and Hedrick, C. (2005) 12/15-Lipoxygenase regulates intercellular adhesion molecule-1 expression and monocyte adhesion to endothelium through activation of RhoA and nuclear factor-kB. Arteriosclerosis Thrombosis, and Vascular Biology, 25, 2301.
25. Maglott, D., Ostell, J., Pruitt, K. and Tatusova, T. (2005) Entrez Gene: genecentered information at NCBI. Nucleic Acids Research. 33, D54-D58 (database issue).
26. Harari, O., McHale, J., Marshall, D., Ahmed, S., Brown, D., Askenase, P. and Haskard, D. (1999) Endothelial cell E- and P-selectin up-regulation in murine contact sensitivity is prolonged by distinct mechanisms occurring in sequence. Journal of Immunology, 163 (12), 6860-6866.
27. Hetzel, J., Balletshofer, B., Rittig, K., Walcher, D., Kratzer, W., Hombach, V., Haring, H., Koenig, W. and Marx, N. (2005) Rapid effects of rosiglitazone treatment on endothelial function and inflammatory biomarkers. Arteriosclerosis, Thrombosis, and Vascular Biology, 25 (9), 1804-1809.
28. Eriksson, E., Karlof, E., Lundmark, K., Rotzius, P., Hedin, U. and Xie, X. (2005) Powerful inflammatory properties of large vein endothelium in vivo. Arteriosclerosis Thrombosis, and Vascular Biology, 25 (4), 723-728.
29. Lo, K., Kan, H., Chan, L., Xu, W., Wang, K., Wu, Z., Sheng, M. and Zhang, M. (2005) The 8-kDa dynein light chain binds to p53-binding protein 1 and mediates DNA damage-induced p53 nuclear accumulation. Journal of Biological Chemistry, 280 (9), 8172-8179.
30. Erkilic, K., Evereklioglu, C., Cekmen, M., Ozkiris, A., Duygulu, F. and Dogan, H. (2003) Adenosine deaminase enzyme activity is increased and negatively correlates with catalase superoxide dismutase and glutathione peroxidase in patients with Behcet's disease: original contributions/clinical and laboratory investigations. Mediators of Inflammation, 12 (2), 107-116.
31. Sato, N., Kokame, K., Shimokado, K., Kato, H. and Miyata, T. (1998) Changes of gene expression by lysophosphatidylcholine in vascular endothelial cells: 12 up-regulated distinct genes including 5 cell growth-related 3 thrombosis-related, and 4 others. Journal of Biochemistry, 123 (6), 1119-1126.
32. Shao,W. and Brown, M. (2004) Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy. Breast Cancer Research, 6 (1), 39-52.
33. Motoyama, A. and Hynes, N. (2003) BAD: a good therapeutic target? Breast Cancer Research, 5 (1), 27-30.
34. Mehra, R., Varambally, S., Ding, L., Shen, R., Sabel, M., Ghosh, D., Chinnaiyan, A. and Kleer, C. (2005) Identification of GATA3 as a breast cancer prognostic marker by global gene expression metaanalysis. Cancer Research, 65 (24), 11259-11264.
35. Perumal, S., Shanthi, P. and Sachdanandam, P. (2005) Therapeutic effect of tamoxifen and energymodulating vitamins on carbohydratemetabolizing enzymes in breast cancer. Cancer Chemotherapy and Pharmacology, 56 (1), 105-114.
36. Alarcon, C., Wicksteed, B., Prenki, M., Corkey, B. and Rhodes, C. (2002) Succinate is a preferential metabolic stimulus-coupling signal for glucoseinduced proinsulin biosynthesis translation. Diabetes, 51, 2496-2504.
37. Gopalakrishnan, V., Arunakaran, J., Aruldhas, M. and Srinivasan, N. (2006) Effects of streptozotocin-induced diabetes mellitus on some bone turnover markers in the vertebrae of ovary-intact and ovariectomized adult rats. Biochemistry and Cell Biology, 84 (5), 728-736.
38. McKenzie, J., Fisher, B., Jaap, A., Stanley, A., Paterson, K. and Sattar, N. (2006) Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial. Clinical Endocrinology, 65 (1), 40-44.
39. Park, S., Cho, Y., Kim, H., Hong, E., Higashimori, T., Lee, S., Goldberg, I., Shulman, G., Najjar, S. and Kim, J. (2006) Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. American Journal of Physiology. Endocrinology and Metabolism, 291 (3), E517-E524.
40. Dubois, M., Bergeron, S., Kim, H., Dombrowski, L., Perreault, M., Fournes, B., Faure, R., Olivier, M., Beauchemin, N., Shulman, G., Siminovitch, K., Kim, J. and Marette, A. (2006) The SHP-1 protein tyrosine phosphatase negatively modulates glucose homeostasis. Nature Medicine, 12 (5), 549-556.
41. Poy, M., Yang, Y., Rezaei, K., Fernstrom, M., Lee, A., Kido, Y., Erickson, S. and Najjar, S. (2002) CEACAM1 regulates insulin clearance in liver. Nature Genetics, 30 (3), 270-276.
42. Yan, G., Fu, Y. and Faustman, D. (1997) Reduced expression of Tap1 and Lmp2 antigen-processing genes in the nonobese diabetic (NOD) mouse due to a mutation in their shared bidirectional promoter. Journal of Immunology, 159 (6), 3068-3080.
43. Kostyak, J., Kimball, S., Jefferson, L. and Farrell, P. (2001) Severe diabetes inhibits resistance exercise-induced increase in eukaryotic initiation factor 2B activity. Journal of Applied Physiology, 91, 79-84.
44. Dahlquist, K., Salomonis, N., Vranizan, K., Lawlor, S. and Conklin, B. (2002) GenMAPP a new tool for viewing and analyzing microarray data on biological pathways. Nature Genetics, 31, 19-20.
45. Efron, B. and Tibshirani, R. (1997) Improvements on cross-validation: the.632+ bootstrap estimator. Journal of the American Statistical Association, 92 (438), 548-560.
46. Braga-Neto, U. and Dougherty, E. (2004) Is cross-validation valid for small-sample microarray classification? Bioinformatics (Oxford, England), 20 (3), 374-380.
47. Fu, W., Carroll, R. and Wang, S. (2005) Estimating misclassification error with small samples via bootstrap crossvalidation. Bioinformatics (Oxford, England), 21 (9), 1979-1986.
48. Molinaro, A., Simon, R. and Pfeiffer, R. (2005) Prediction error estimation: a comparison of resampling methods. Bioinformatics (Oxford, England), 21 (15), 3301-3307.
49. Mootha, V., Handschin, C., Arlow, D., Xie, X., Pierre, J., Sihag, S., Yang, W., Altshuler, D., Puigserver, P., Patterson, N., Willy, P., Schulman, I., Heyman, R., Lander, E. and Spiegelman, B. (2004) Erra and Gabpa/b specify PGC-1adependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proceedings of the National Academy of Sciences of United States of America, 101, 6570-6575.
50. Misu, H., Takamura, T., Matsuzawa, N., Shimizu, A., Ota, T., Sakurai, M., Ando, H., Arai, K., Yamashita, T., Honda, M., Yamashita, T. and Kaneko, S. (2007) Genes involved in oxidative phosphorylation are coordinately upregulated with fasting hyperglycaemia in livers of patients with type 2 diabetes. Diabetologia, 50, 268-277.
51. Razeghi, P., Young, M., Cockrill, T., Frazier, O. and Taegtmeyer, H. (2002) Downregulation of myocardial myocyte enhancer factor 2C and myocyte enhancer factor 2C regulated gene expression in diabetic patients with nonischemic heart failure. Journal of the American Heart Association, 106, 407-411.
52. Voisine, P., Ruel, M., Khan, T., Bianchi, C., Xu, S., Kohane, I., Libermann, T., Otu, H., Saltiel, A. and Sellke, F. (2004) Differences in gene expression profiles of diabetic and nondiabetic patients undergoing cardiopulmonary bypass and cardioplegic arrest. Journal of the AmericanHeart Association, 110, 280-286.
53. Zhang, D., Zhou, Z., Li, L., Weng, J., Huang, G., Jing, P., Zhang, C., Peng, J. and Xiu, L. (2005) Islet autoimmunity and genetic mutations in Chinese subjects initially thought to have Type 1B diabetes. Diabetic Medicine, 23, 67-71.
54. Chen, Q., Behar, K.L., Xu, T., Fan, C. and Haddad, G. (2003) Expression of Drosophila trehalose-phosphate synthase in HEK-293 cells increases hypoxia tolerance. Journal of Biological Chemistry, 278, 49113-49118.